TibaRay Inc.

TibaRay is pioneering the future of cancer care with ultra-rapid, high-efficiancy linear accelerator technology designed to make radiotherapy faster, more precise, and broadly accessible worldwide.

Spun out of decades of physics and oncology research at Stanford University and backed by 21 issued and pending patents, TibaRay’s Galactica™ platform is engineered to unlock sub-second FLASH radiotherapy. By delivering curative radiation doses in fractions of a second instead of minutes, our technology is designed to freeze physiological tumor motion and spare healthy surrounding tissue.

Subscribe for:

Episodes of The FLASH Effect Podcast with TibaRay & industry leaders

Behind-the-scenes progress from our 24,000 sq. ft. Silicon Valley production facility

Commercial integration updates with Leo Cancer Care and the clinical pipeline at Mayo Clinic

⚡ Learn more about our active community raise: https://wefunder.com/tibaray